Vitamin D3 for Life

Live Enlightened

Article

VDR-Related Alopecia and Unliganded Hair-Follicle Biology: Evidence Synthesis

Previous related pageSunscreen Use and Vitamin D SynthesisNext related pageVitamin D and Epithelial Barrier Failure Across Gut, Lung and Skin: Full Evidence Review
Study at a glance

Why can rare vitamin D receptor disorders cause hair loss?

The vitamin D receptor helps hair follicles maintain their growth cycle. Some inherited defects remove the receptor or damage functions needed for that cycle, causing hair loss alongside the effects on calcium and bone.

Why do some affected people keep their hair?

Different gene changes damage different receptor functions. Some greatly weaken the response to active vitamin D while leaving the hair growth cycle intact. This supports a role for the receptor in hair follicles that does not depend on its usual signal from active vitamin D.

Does this mean vitamin D supplements will treat ordinary hair loss?

No. These findings concern rare inherited disorders and experimental models. They do not show that common hair loss usually comes from these gene changes or that taking more vitamin D will correct it.

Read the full article below ↓

Alopecia in hereditary VDR disorders is scientifically useful because it does not simply track the severity of resistance to 1,25-dihydroxyvitamin D. Some mutations cause profound endocrine resistance without hair loss, while others that remove receptor expression, DNA binding or selected dimerisation functions are strongly associated with alopecia. That pattern reveals a VDR requirement in hair-follicle biology that cannot be explained by classical ligand-dependent mineral signalling alone.

For the wider rare-disease mutation spectrum and mineral phenotype, see Pathogenic VDR Mutations and Hereditary Vitamin D-Resistant Rickets.

Hair loss does not simply mean ‘more severe HVDRR’

HVDRR causes resistance to 1,25-dihydroxyvitamin D, impaired intestinal calcium absorption and the familiar mineral consequences of hypocalcaemia, secondary hyperparathyroidism, hypophosphataemia and rickets. Alopecia is different: it occurs in only a subset of affected children and depends strongly on the molecular class of the VDR defect. The hair phenotype therefore provides a second readout of receptor biology rather than a simple severity scale for the endocrine disease.

DNA-binding defects and absent receptor are particularly informative

Malloy and Feldman’s synthesis of human mutations reports a consistent pattern. Mutations that abolish VDR expression, disrupt the receptor’s DNA-binding function or impair RXR heterodimerisation are associated with alopecia. DNA-binding-domain mutations are especially striking because ligand binding can remain intact while DNA interaction fails. Severe hormone resistance plus alopecia in that setting points toward a requirement for an intact receptor: DNA regulatory apparatus in hair cycling.

The 2014 patient study gives the pattern concrete examples. A C60W mutation in the second zinc finger of the DNA-binding domain was completely inactive in transactivation assays and occurred with alopecia. Across the mutation catalogue summarised by the authors, DNA-binding-domain mutations were strongly associated with hair loss.

Ligand-binding and coactivator defects can separate endocrine resistance from hair cycling

The converse cases are equally important. Mutations that lower VDR affinity for 1,25-dihydroxyvitamin D or disrupt coactivator interactions can cause severe hormone resistance without alopecia. In the five-patient report, D144N and R158C ligand-binding-domain defects were examples in which rickets and hormone resistance occurred without hair loss. A compound-heterozygous patient carrying a DNA-binding-domain mutation together with an N276Y ligand-binding-domain allele also lacked alopecia, suggesting that the second allele could preserve a hair-relevant receptor function even though it did not prevent the mineral phenotype.

This is the critical natural experiment. If hair cycling depended simply on ligand-induced transcriptional potency, then mutations that severely weaken ligand binding should consistently produce alopecia. They do not. The mutation pattern instead supports a function of VDR in hair follicles that can persist when canonical ligand-dependent activation is badly impaired.

Why the evidence points to an unliganded VDR function

The human mutation pattern converges with model evidence discussed in the authorised reviews. People with vitamin D deficiency or defects in 1α-hydroxylase do not show the same characteristic alopecia, whereas loss of VDR itself does. In VDR-null mice, restoring wild-type VDR in keratinocytes can restore hair cycling. These comparisons separate absence of ligand production from absence of the receptor protein and support the conclusion that the receptor has a hair-follicle role that does not require the classical ligand signal in the same way as mineral metabolism.

Calling this ‘ligand-independent’ or ‘unliganded’ does not mean VDR has no ligand-dependent actions in skin. It means the hair-cycle requirement exposed by these genetic comparisons cannot be reduced to the receptor’s ordinary calcitriol-dependent endocrine action.

The receptor probably works with a hair-follicle regulatory programme

The exact downstream mechanism remains incompletely resolved. The alopecia phenotype of VDR loss resembles disorders involving the hairless (HR) corepressor pathway, and experimental work has implicated interactions among VDR, HR and broader pathways involved in keratinocyte and hair-follicle differentiation. Human mutation evidence therefore identifies the requirement for receptor integrity more strongly than it identifies one final molecular pathway.

What the evidence does not establish

The authorised evidence is derived from a rare Mendelian disorder, small patient series and mechanistic synthesis. It does not imply that ordinary hair loss in the general population is usually caused by VDR mutations or that increasing vitamin D exposure will correct alopecia. Nor does it make alopecia inevitable in HVDRR. The scientifically useful conclusion is narrower: mutation class separates the receptor’s ligand-dependent endocrine role from a receptor-dependent hair-follicle function.

Primary evidence used in this synthesis

  • Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets · BoneKEy Rep. 2014;3:510. DOI: 10.1038/bonekey.2014.5.
  • Vitamin D Receptor Mutations in Patients with Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets · Mol Genet Metab. 2014. DOI: 10.1016/j.ymgme.2013.10.014.
  • The role of vitamin D receptor mutations in the development of alopecia · Mol Cell Endocrinol. 2011;347(1 to 2):90 to 96. DOI: 10.1016/j.mce.2011.05.045.

Related reading

Original sources